Cannabix Technologies Inc. just announced breaking news that, ?It has entered into a strategic partnership and development agreement dated May 15, 2024 with Omega Laboratories Inc. of Ohio, USA (Omega Laboratories or ?Omega). The Agreement provides a pathway for commercialization of Cannabix?s marijuana breathalyzer technology. Omega Laboratories is an international industry leader in forensic drugs of abuse testing for over twenty years.

Omega has multiple federal as well as international certifications and accreditations for its world class facility and has extensive experience in novel technology for detection of drugs of abuse. Pursuant to the Agreement, Cannabix and Omega Laboratories (together, the Parties) have agreed to, among other things, complete research and development, refine and expand the use of Cannabix?s technology to meet existing and emerging needs of Omega?s clients, contemplate manufacturing and distribution and introduce the delta9 THC breath testing technology to customers in North America. Omega Laboratories is headquartered in Ohio, USA in a facility providing drugs of abuse testing to over 6,000 clients worldwide, including several Fortune 500 companies police and highway patrols, several court systems, military organizations, and school systems. Omega also has one of the largest Third-Party Administrator (TPA) client lists in America.